Skip to content

Medinotec Inc.: 10-Q filed 2023-01-17

What Medinotec Inc. reported in its quarterly report filed 2023-01-17 (fiscal Q3 2023): 36 published measures, 120 facts as tagged in accession 0001663577-23-000010.

This filing

Form
10-Q (quarterly report)
Filed
2023-01-17
Fiscal period
fiscal Q3 2023
Accession
0001663577-23-000010 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Medinotec Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-11-305,092,265USD
At 2022-02-281,323,031USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-11-302,507,798USD
At 2022-02-281,793,016USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-11-302,944,370USD
At 2022-08-312,993,157USD
At 2022-02-28-110,082USD
At 2021-11-30-100,632USD
At 2021-08-31-25,078USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-09-01 to 2022-11-30-36,341USD91
2022-03-01 to 2022-11-30-289,077USD275
2022-07-01 to 2022-09-30-36,341USD92
2021-09-01 to 2021-11-30-74,428USD91
2021-03-01 to 2021-11-30-110,520USD275
2021-07-01 to 2021-09-30-74,428USD92
2021-01-01 to 2021-09-30-110,520USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-03-01 to 2022-11-30-848,140USD275
2022-07-01 to 2022-09-30-255,576USD92
2021-07-01 to 2021-09-30-468,879USD92
2021-01-01 to 2021-09-30-637,179USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2022-03-01 to 2022-11-3057,042USD275
2022-07-01 to 2022-09-3027,482USD92
2021-07-01 to 2021-09-3023,485USD92
2021-01-01 to 2021-09-3039,902USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2022-03-01 to 2022-11-30720,339USD275
2022-07-01 to 2022-09-30387,989USD92
2021-07-01 to 2021-09-30180,748USD92
2021-01-01 to 2021-09-30450,311USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-03-01 to 2022-11-304,229,838USD275
2022-07-01 to 2022-09-30328,214USD92
2021-07-01 to 2021-09-30509,567USD92
2021-01-01 to 2021-09-30804,812USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-03-01 to 2022-11-30-651,285USD275
2022-07-01 to 2022-09-30-621,725USD92
2021-07-01 to 2021-09-30-23,485USD92
2021-01-01 to 2021-09-30-39,913USD273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-03-01 to 2022-11-300USD/shares275
2022-07-01 to 2022-09-300USD/shares92
2021-07-01 to 2021-09-300USD/shares92
2021-01-01 to 2021-09-300USD/shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2022-11-30455,421USD
At 2022-02-28515,703USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2022-03-01 to 2022-11-30-195,091USD275
2022-07-01 to 2022-09-3025,499USD92
2021-07-01 to 2021-09-30-70,236USD92
2021-01-01 to 2021-09-30-106,122USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2022-11-303,933,651USD
At 2022-02-28721,702USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2022-11-30178,804USD
At 2022-02-28209,019USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2022-11-30283,401USD
At 2022-02-2842,183USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2022-03-01 to 2022-11-30-615,288USD275
2022-07-01 to 2022-09-30-197,805USD92
2021-07-01 to 2021-09-30-178,684USD92
2021-01-01 to 2021-09-30-415,282USD273

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2022-03-01 to 2022-11-30420,197USD275
2022-07-01 to 2022-09-30223,304USD92
2021-07-01 to 2021-09-30108,448USD92
2021-01-01 to 2021-09-30309,160USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2022-03-01 to 2022-11-30-300,142USD275
2022-07-01 to 2022-09-30-164,685USD92
2021-07-01 to 2021-09-3072,300USD92
2021-01-01 to 2021-09-30-141,151USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2022-03-01 to 2022-11-30-62,356USD275
2022-07-01 to 2022-09-30-6,405USD92
2021-07-01 to 2021-09-30-12,624USD92
2021-01-01 to 2021-09-3025,821USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-11-3011,734shares
At 2022-02-2810,000shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2022-11-302,846,793USD
At 2022-09-302,846,793USD
At 2022-06-303,385,717USD
At 2022-02-28131,573USD
At 2021-09-30168,658USD
At 2021-06-30170,067USD
At 2020-12-3180,975USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2022-11-303,296,391USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2022-11-3042,485USD
At 2022-02-28-2,895USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2022-11-302,584,467USD
At 2022-02-28-469,985USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2022-11-301,840,965USD
At 2022-02-281,992,559USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2022-11-301,388,093USD
At 2022-02-281,509,747USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2022-03-01 to 2022-11-30-319,982USD275
2022-07-01 to 2022-09-30-16,781USD92
2021-07-01 to 2021-09-30-74,428USD92
2021-01-01 to 2021-09-30-110,520USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2022-03-01 to 2022-11-30-461,794USD275
2022-07-01 to 2022-09-30-159,822USD92
2021-07-01 to 2021-09-30-129,986USD92
2021-01-01 to 2021-09-30318,393USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2022-03-01 to 2022-11-3064,153USD275
2022-07-01 to 2022-09-3019,809USD92
2021-07-01 to 2021-09-3025,322USD92
2021-01-01 to 2021-09-3060,154USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2022-03-01 to 2022-11-3026,353USD275
2022-07-01 to 2022-09-3013,245USD92
2021-07-01 to 2021-09-30291USD92
2021-01-01 to 2021-09-301,651USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2022-03-01 to 2022-11-30-124,891USD275
2022-07-01 to 2022-09-30-42,280USD92
2021-07-01 to 2021-09-30-4,192USD92
2021-01-01 to 2021-09-30-4,398USD273

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2022-09-01 to 2022-11-3019,560USD91
2021-03-01 to 2022-02-28-65,003USD365

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2022-03-01 to 2022-11-30-30,905USD275
2022-07-01 to 2022-09-3019,560USD92

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2022-03-01 to 2022-11-303,467,500USD275
2021-01-01 to 2021-09-3010,000USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2022-03-01 to 2022-11-30250,467USD275
2022-07-01 to 2022-09-30258,411USD92
2021-07-01 to 2021-09-3029,445USD92
2021-01-01 to 2021-09-3015,467USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2022-03-01 to 2022-11-30-309,856USD275
2022-07-01 to 2022-09-30116,448USD92
2021-07-01 to 2021-09-30-516,957USD92
2021-01-01 to 2021-09-30-633,744USD273

Inspect the source

Entity
Medinotec Inc. / CIK 0001931055
Captured
2026-09-21T17:35:00.421Z
SEC response SHA-256
7ac193460ab122408ac6b8ba21f1102b2b4360116069e916909fdfcd34521980

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001931055.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))